EP3642242
DOSING PARAMETERS FOR CD47 TARGETING THERAPIES TO HEMATOLOGIC MALIGNANCIES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
21.6.2018EP published:
7.2.2024EP application number:
18820011.7
EPO information:
European Patent Register
Max expiry date:
20.6.2038
Title in English:
DOSING PARAMETERS FOR CD47 TARGETING THERAPIES TO HEMATOLOGIC MALIGNANCIESLanguage of the patent:
English
Timeline
Today
21.6.2018EP application
7.2.2024EP Publication
Owner
Name:
The Board of Trustees of the Leland Stanford Junior UniversityAddress:
Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038, US
Name:
Forty Seven, Inc.Address:
333 Lakeside Drive, Foster City, CA 94404, US
Inventor
Name:
MAJETI, RavindraAddress:
Palo Alto California 94303, US
Name:
CHAO, Mark P.Address:
Mountain View California 94040, US
Name:
LIU, JieAddress:
Palo Alto California 94303, US
Name:
VOLKMER, Jens-PeterAddress:
Menlo Park California 94025, US
Name:
WEISSMAN, Irving L.Address:
Stanford California 94305, US
Priority
Number:
201762523182 PDate:
21.6.2017Country:
US
Classification
Categories:
C07K 16/28, A61K 39/395